1,953
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease

, , &
Pages 557-566 | Received 27 Jun 2021, Accepted 30 Aug 2021, Published online: 12 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shuai Shao, Zhijin Zhang, Lin Feng, Lirong Liang & Zhaohui Tong. (2023) Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1783-1802.
Read now

Articles from other publishers (4)

Min Xiao, Xiaoyu Wang, Hanchao Wang, Fawang Du, Yu Yao, Xiaochuan Wang, Jiajia Wang, Juan Yang, Wei Xiong, Qin Wang, Xubin Ren & Tao Zhu. (2023) Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study. BMC Pulmonary Medicine 23:1.
Crossref
Wang Ruiying, Zhaoyun & Xu Jianying. (2022) Clinical features and three-year prognosis of AECOPD patients with different levels of blood eosinophils. Heart & Lung 56, pages 29-39.
Crossref
Jun Xia Wang, Ying Zhang, Shu Fang Wang, Juan Li & Peng Cheng Li. (2022) Efficacy of Xiyanping in the Treatment of Elderly Patients with Chronic Obstructive Pulmonary Disease and Its Effect on the Expression of GDF-15 and HIF-1α in Serum. Computational and Mathematical Methods in Medicine 2022, pages 1-8.
Crossref
Shan Mou, Wei Zhang, Yan Deng, Zhijun Tang & Depeng Jiang. (2022) Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients. Canadian Respiratory Journal 2022, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.